CNBX Pharmaceuticals (CNBX) Asset Utilization Ratio (2016 - 2024)
CNBX Pharmaceuticals (CNBX) has disclosed Asset Utilization Ratio for 12 consecutive years, with 1.51 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Asset Utilization Ratio rose 34.29% year-over-year to 1.51, compared with a TTM value of 1.51 through Nov 2024, up 34.29%, and an annual FY2024 reading of 0.49, down 21.67% over the prior year.
- Asset Utilization Ratio was 1.51 for Q4 2024 at CNBX Pharmaceuticals, down from 2.34 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 2.34 in Q3 2024 and bottomed at 0.04 in Q2 2022.
- Average Asset Utilization Ratio over 5 years is 0.59, with a median of 0.0 recorded in 2020.
- The sharpest move saw Asset Utilization Ratio crashed 8910.18% in 2022, then soared 6392.1% in 2024.
- Year by year, Asset Utilization Ratio stood at 0.0 in 2020, then tumbled by 81.75% to 0.0 in 2021, then crashed by 4766.94% to 0.02 in 2022, then soared by 4898.05% to 1.13 in 2023, then skyrocketed by 34.29% to 1.51 in 2024.
- Business Quant data shows Asset Utilization Ratio for CNBX at 1.51 in Q4 2024, 2.34 in Q3 2024, and 1.89 in Q2 2024.